Effect of tumor susceptibitity gene 101-siRNA eukaryotic expression vector and cisplatin on proliferation of QGY/CDDP

向征; 张才全; 汤为学

您当前的位置：

首页 >

文章列表页 >

Effect of tumor susceptibitity gene 101-siRNA eukaryotic expression vector and cisplatin on proliferation of QGY/CDDP

更新时间：2026-01-09

- Effect of tumor susceptibitity gene 101-siRNA eukaryotic expression vector and cisplatin on proliferation of QGY/CDDP
- Journal of Army Medical University Vol. 30, Issue 2, Pages: 170-173(2008)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R394-33;R73-362;R735.7
- Published：2008
- 稿件说明：
移动端阅览
向征,张才全,汤为学.TSG101-siRNA对肝癌耐药细胞株QGY/CDDP的逆转作用[J].陆军军医大学学报(原第三军医大学学报),2008,30(02):170-173.

　XIANG Zheng,ZHANG Cai-quan,TANG Wei-xue.Effect of tumor susceptibitity gene 101-siRNA eukaryotic expression vector and cisplatin on proliferation of QGY/CDDP[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(02):170-173.
向征,张才全,汤为学.TSG101-siRNA对肝癌耐药细胞株QGY/CDDP的逆转作用[J].陆军军医大学学报(原第三军医大学学报),2008,30(02):170-173. DOI：

　XIANG Zheng,ZHANG Cai-quan,TANG Wei-xue.Effect of tumor susceptibitity gene 101-siRNA eukaryotic expression vector and cisplatin on proliferation of QGY/CDDP[J].J Amry Med Univ (J Third Mil Med Univ),2008,30(02):170-173. DOI：

摘要

目的构建TSG101（tumor susceptibility gene101）小干扰RNA（TSG101-siRNA）的真核表达载体，观察RNA干扰沉默TSG101基因后化疗药物顺铂（CDDP）对肝癌耐药细胞株QGY/CDDP增殖的影响。方法根据小干扰RNA的设计原则由计算机软件辅助设计TSG101的靶序列，应用DNA重组技术将目的序列克隆入小干扰RNA的表达载体； RT-PCR检测TSG101-siRNA对QGY/CDDP细胞tsg101mRNA表达的影响；Western blot检测TSG101-siRNA对TSG101基因表达蛋白的抑制效率；采用MTT法测定TSG101-siRNA联合化疗药物CDDP对QGY/CDDP的增殖抑制作用。结果测序显示干扰载体构建成功，TSG101-siRNA能抑制tsg101mRNA表达，使QGY/CDDP细胞TSG101蛋白的表达下降，抑制QGY/CDDP细胞的增殖，明显增强CDDP对QGY/CDDP的增殖抑制。结论 TSG101-siRNA的真核表达载体能有效地抑制QGY/CDDP细胞的增殖，提高化疗药物CDDP对QGY/CDDP的抑制率，能逆转肝癌耐药细胞株QGY/CDDP对CDDP的耐药性。

Abstract

Objective To construct the eukaryotic expression plasmids of tumor susceptibitity gene(TSG) 101-siRNA and investigate the effect of RNA interference targeting tsg101 gene and cisplatin on liver cancer resistant strain QGY/CDDP. Methods The targeting fragments specifically against TSG101 were designed according to the principle of small interfering RNA designation using computer software. The sequences were cloned into siRNA expression plasmids through DNA recombinant technology. The expressions of tsg101mRNA and TSG101 after TSG101-siRNA transfection was detected by RT-PCR and Western blot respectively. MTT test were applied to measure the proliferation of QGY/CDDP strain. Results The fragments of interest were obtained by digestion and further confirmed by DNA sequencing. TSG101-siRNA inhibited the expressions of tsg101mRNA and TSG101 and the proliferation of QGY/CDDP

especially in combination with cisplatin. Conclusion The eukaryotic expression vector of TSG101-siRNA combined with cisplatin inhibits the proliferation of QGY/CDDP and increases the sensitivity of liver cancer resistant strain QGY/CDDP to chemotherapy.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Failure to perform second-stage operation after first one of associating liver partition and portal vein ligation for staged hepatectomy: analysis of 62 cases

Mechanism of hepatitis B virus X inducing hepatocellular carcinoma in mice through COX-2 and its downstream factors

Screening of hALR-specific binding peptide from phage display peptide library and its biological activities of inhibiting liver cancer

Sorting and cancer stem cell characteristic analysis of CD13⁺CD133⁺HCC cells in HuH7 cell line

Role JAK2/STAT3 signaling pathway in invasion and vascular mimicry of liver cancer cells

Related Author

张雷达

马宽生

冯凯

欧晏娇

何明莲

邓青松

杜彬

毋楠

Related Institution

No data

⁰